D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TXG holding history
10x Genomics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXG overviewAll 13F holders of TXGFull Q2 2026 holdings
- Shares (Q2 2026)
- 233,069
- Value
- $8.94M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 233,069 | $8.94M | <0.1% | +164,512+240.0% | Added | Holders |
| Q1 2026 | 68,557 | $1.46M | <0.1% | −105,911−60.7% | Reduced | Holders |
| Q4 2025 | 174,468 | $2.85M | <0.1% | +11,560+7.1% | Added | Holders |
| Q3 2025 | 162,908 | $1.90M | <0.1% | −583,358−78.2% | Reduced | Holders |
| Q2 2025 | 746,266 | $8.64M | <0.1% | −1,235,997−62.4% | Reduced | Holders |
| Q1 2025 | 1,982,263 | $17.3M | <0.1% | +763,665+62.7% | Added | Holders |
| Q4 2024 | 1,218,598 | $17.5M | <0.1% | +1,218,598 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −64,799−100.0% | Sold out | Holders |
| Q1 2024 | 64,799 | $2.43M | <0.1% | +59,855+1,210.7% | Added | Holders |
| Q4 2023 | 4,944 | $276.7K | <0.1% | −55,361−91.8% | Reduced | Holders |
| Q3 2023 | 60,305 | $2.49M | <0.1% | −47,225−43.9% | Reduced | Holders |
| Q2 2023 | 107,530 | $6.00M | <0.1% | +97,299+951.0% | Added | Holders |
| Q1 2023 | 10,231 | $570.8K | <0.1% | −184,026−94.7% | Reduced | Holders |
| Q4 2022 | 194,257 | $7.08M | <0.1% | +194,257 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −3,402−100.0% | Sold out | Holders |
| Q3 2021 | 3,402 | $495.0K | <0.1% | −32,334−90.5% | Reduced | Holders |
| Q2 2021 | 35,736 | $7.00M | <0.1% | −55,177−60.7% | Reduced | Holders |
| Q1 2021 | 90,913 | $16.5M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.